Management

As the Founder and Chief Medical Officer of Clintara, Dr. Targum consults widely to the pharmaceutical industry regarding the design and implementation of clinical trials for new psychotropic drugs and the progression of drug development from concept to approval to launch. In addition to his work at Clintara, Dr. Targum is a consultant in psychiatry at Massachusetts General Hospital, Chief Medical Advisor at Prana Biotechnology Ltd., and has served as Chief Medical Officer at several small biotechnology and pharmaceutical companies.

In 1991, Dr. Targum established and operated a multi-site clinical trials program in Philadelphia. As Principal Investigator, he conducted over 200 clinical drug trials in therapeutic areas that included anxiety, depression, mania, schizophrenia, and Alzheimer’s disease.

In 2001, Dr. Targum founded PharmaStar, a rater training and medical education company focused on CNS drug development and international clinical trials. The company grew quickly and became the global leader in this niche when it was sold in October 2004 to United BioSource Corporation.

Currently, Dr. Targum is a consultant in psychiatry at the Massachusetts General Hospital. Previously, He was Professor of Psychiatry and Vice-Chairman of the Department of Mental Health Sciences at Hahnemann University School of Medicine (Philadelphia) from 1989-1995. He has published over 100 scientific articles in the areas of psychopharmacology, psychobiology, and clinical trials methodology.

Dr. Targum has a B.A. in biology from Colgate University and an M.D. from Mount Sinai School of Medicine.

View Dr. Targum’s complete CV

Mr. Bower brings extensive business consulting and senior executive experience, having managed and driven substantial growth of public and private companies on a global scale. Colin led Arthur Andersen’s multi-million dollar global capital markets practice, providing advisory, strategy and transaction services to multinational clients and sovereign entities across EMEA and APAC.

Prior to joining Andersen, Colin was a US Presidential Appointee at the US Department of the Treasury. Upon leaving Andersen, Colin successfully managed and grew high growth companies to capital events, and was the founder and general partner of a private equity fund.

Colin has a BA from McGill University, an MBA from the University of Chicago Booth School of Business, and a Certificate in Advanced Corporate Finance from INSEAD, France.

Stephen Saber is the CEO of CrossTech Ventures – the parent company of Clintara, New Marketing Labs, The Pulse Network, CrossTech Media, and CrossTech Partners. Prior to that Stephen served as President and Director of Exgenex, a full services event and lead management organization providing technology tools and solutions to the event industry, since its inception in 1993. Before launching Exgenex, Stephen served as a managing director at Cambridge Technology Partners, a pre-IPO IT Services organization where he sold and managed multi-million dollar software development projects to re-engineer businesses through innovative uses of technology.

Stephen is also a managing director in several conference and education programs with a focus on K-12 Education, Content Management Technologies, Compliance Solutions, and Communications Strategies.

During his career, Stephen has developed seminars and lectures produced globally for senior IT executives. These programs focused on business remodeling and reengineering as a technique to redefine business processes and implement new technologies. He has spoken in Tokyo, Singapore, and throughout the United States on the topic.

Stephen is currently a guest lecturer at Babson College in the entrepreneurship program speaking to both undergraduate and graduate programs.

Stephen received his M.B.A. and B.A. from Harvard University.

in/ssaber

Dr. Pendergrass has extensive experience in developing and executing comprehensive clinical studies involving various psychiatric populations, including schizophrenia, bipolar disorder, depression, and dementia in addition to specialty training in clinical neuropsychology and neuroimaging.

Her expertise in multiple methodologies, including a wide range of clinical interviews, questionnaires, neuropsychological evaluations, cognitive neuroscience tasks, and neuroimaging, affords her the opportunity to better conduct translational research and examine different mechanisms that contribute to the development, maintenance, and worsening of clinical and cognitive symptoms in psychiatric disorders, which ultimately may be targets for treatment and/or psychotherapeutic intervention.

In 2003, Dr. Pendergrass received an Early Career Investigator Award from the College on Problems of Drug Dependence and a Junior Investigator Travel Award from the National Institute on Drug Abuse (NIDA).

As a fellow at Dartmouth Medical School, Dr. Pendergrass contributed to the Alzheimer’s Disease Neuroimaging Initiative (ADNI), a multisite longitudinal clinical/imaging/genetic biomarker study with the goals of defining the progression of Alzheimer’s Disease, identification of biomarkers, and the discovery and development of treatments.

Dr. Pendergrass also maintains her clinical license as a psychologist with a specialty in Neuropsychology. She is scheduled to complete her Board Certification in Clinical Neuropsychology in the Fall of 2012. She has worked extensively with severe and chronically mentally ill, geriatric, medically ill, and neurological patient populations. She also has specialty training in treating Obsessive Compulsive Disorder and Posttraumatic Stress Disorder.

Dr. Pendergrass graduated with a B.A. in Psychology with Honors from Vanderbilt University and obtained an M.S. and Ph.D. in Clinical Psychology with a specialization in Neuropsychology from Rosalind Franklin University of Medicine and Science. She completed her internship and post-doctoral fellowship in Clinical Neuropsychology at the University of Illinois-Chicago and Dartmouth Medical School, respectively.

Philip Rauh holds a MA of International Economics with emphasis on quantitative analysis from the Graduate Institute of International Studies of the University of Geneva in Switzerland. He has spent most of his career in the financial service industry and has worked in various European countries as well as the US and Canada. He held various leading roles in the areas of data analysis, client management and process implementation.

Philip recently joined Clintara from a Boston based private equity boutique where he was responsible for global client and sales management and a member of the executive board. At Clintara Philip oversees client services with a focus on product and service delivery and quality control.

Mr. West brings extensive operations and management experience to Clintara. His background includes project management, software engineering, sales and executive management.

Mark is an experienced senior executive. Most recently as President and CFO of SenovvA, Mark was responsible for business strategy, financial management and sales management. Mark increased sales from $2.4M in 2006 to $5.6M in 2008, and led the company to be recognized as one of the Top 100 Fastest Growing Private Companies in Los Angeles, 2009.

As Vice President for United BioSource Corporation Training and Education Group (formerly PharmaStar), Mark was responsible for sales and operations for a multi-national corporation working for the top pharmaceutical companies in the world, doubling year-over-year growth for three consecutive years and expanding the company into both European and Japanese markets. UBC provides custom training and education events for pharmaceutical companies world-wide. During his tenure with the company, Mark was personally responsible for the delivery of services to dozens of clients.

In addition, Mark has years of experience as a software engineer and project manager designing, developing, and implementing software for the healthcare, manufacturing, financial and aerospace industries.

in/markwest

Jeannie Edfort brings 25 years of experience in the pharmaceutical industry to Clintara. She began her career as a pharmaceutical microbiologist at an analytical laboratory, coordinating a group of laboratory technicians, and researching and writing new test methodologies. Midway through her ten years at the laboratory, Ms. Edfort was asked to start a new Client Services department for the pharmaceutical division, where she became responsible for internal client services and external sales. After developing a successful team, Ms. Edfort spent the next 10+ years in key business development positions for major global CROs, and a start-up venture funded technology company designed around minimizing the impact of subjective endpoints in clinical trials. Most recently, Ms. Edfort was Director, Business Development for United BioSource Corporation, where she was the 2007 Circle of Excellence award recipient.

In addition to her pharmaceutical experience, Ms. Edfort has also pursued other creative and business activities. She was Finance Director for a state-wide gubernatorial campaign in 2009-2010, and is an accomplished bridal and fashion accessories designer.

Ms. Edfort was a Presidential Scholar, and graduated with honors with a BS in Biology/Pre-Medicine from Lambuth College in Jackson, TN.

LinkedIn

Tony Parham is the Director of Technology / CTO at Clintara, LLC, where he leads IT services and product management for Clintara’s SaaS offering to the pharmaceutical and clinical research industries.

Tony’s other CrossTech Ventures roles have included:

- New Marketing Labs (founded by social media pioneer Chris Brogan):

As Executive Director, Tony was responsible for product management, client account management and business development.

- The Pulse Network: Host of NML TV (a cutting-edge Internet TV program re: digital andsocial media marketing)

Tony is experienced in leading high profile, global initiatives. He has a strategic perspective, with a track record of success in business plan creation, product management, product marketing and partnership development.

Tony joined CrossTech Ventures from serving as Managing Director at TKG Management Consulting. Earlier in his career, Tony worked as Program Director for e-business Transformation for IBM Software Group, guiding IBM Software Group to become a market leader in doing business via the web withcustomers, partners, influencers and employees.

Prior to his IBM roles, Tony held a variety of positions at Lotus Development Corporation, including: Director of e-business Strategy, Director of Marketing & Business Partner Programs for the Telco & ISP Solutions Division, Senior Product Marketing Manager for AT&T Network Notes, Group Product Manager for Lotus Notes and Product Manager for Unix Products.

Tony holds an M.S. in Management from the MIT Sloan School of Management (designated as Seley Scholar: Sloan’s highest honor), has served as a member of Sloan’s Board of Governors and has been an occasional guest lecturer in their marketing department and in various school-wide forums. Tony has also earned an M.S. in Computer Science from the University of Southern California and a B.S. in Computer Science from MIT.

in/tonyparham